
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 309913-83-5 |
| Catalog No. | 2A-9056472 |
| Chinese Name | 他匹莫德 |
| Synonyms | SCIO-469; Scios 469; Talmapimod |
| Molecular Formula | C27H30ClFN4O3 |
| Molecular Weight | 513.00 |
| Purity | ≥98 (HPLC) |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 658.0±65.0 °C at 760 mmHg |
| Appearance | powder |
| Storage Condition | -20°C, sealed, dry |
| Application | Talmapimod (SCIO-469) is a selective ATP competitive inhibitor of p38 with an IC50 value of 9 nM. |
| MDL Number | MFCD11973651 |
| SMILES | O=C(C(C1=CN(C2=C1C=C(C(Cl)=C2)C(N3[C@@H](CN([C@H](C3)C)CC4=CC=C(C=C4)F)C)=O)C)=O)N(C)C |
| InChI | 1S/C27H30ClFN4O3/c1-16-13-33(17(2)12-32(16)14-18-6-8-19(29)9-7-18)26(35)21-10-20-22(25(34)27(36)30(3)4)15-31(5)24(20)11-23(21)28/h6-11,15-17H,12-14H2,1-5H3/t16-,17+/m0/s1 |
| InChI Key | ZMELOYOKMZBMRB-DLBZAZTESA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| MSDS | msds/56472_1_309913_83_5.pdf |
| Transport Info | Product name: SCIO 469 hydrochloride |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Ethyl 3-(chlorosulfonyl)isonicotinate | 306936-12-9 | 2A-9056453 |
| tert-Butyl N-(4-bromo-2-methylphenyl)carbamate | 306937-14-4 | 2A-9056455 |
| 5,6-Diamino-1,3-naphthalenedisulfonic acid dipotassium salt | 307495-30-3 | 2A-9056462 |
| N-tert-Butyl-3-bromobenzenesulfonamide | 308283-47-8 | 2A-9056467 |
| Bis(ethylcyclopentadienyl)tungsten(IV) dihydride | 308847-90-7 | 2A-9056469 |
| 2-((E)-2-(2-Chloro-3-[(E)-2-(1,3,3-trimethyl-1,3-dihydro-2H-benzo[g]indol-2-ylidene)ethylidene]-1-cyclohexen-1-yl)ethenyl)-1,3,3-trimethyl-3H-benzo[g]indolium 4-methylbenzenesulfonate | 309967-80-4 | 2A-9056473 |
| 3-Amino-3-(4-isopropoxyphenyl)propanoic acid | 311321-19-4 | 2A-9056478 |
| 9-Iodo-10-phenylphenanthrene | 312612-61-6 | 2A-9056479 |
| D-S-Isoamylcysteine | 312746-71-7 | 2A-9056486 |
| 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | 312753-53-0 | 2A-9056489 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA